A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway

Overview of attention for article published in BMC Cancer, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Readers on

mendeley: 22 Mendeley

Summary News X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,513 followers.

A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway. #lymphoma #lymsm https://t.co/j1OxvNpEv2

12 May 2020

Reply Repost Favourite

A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway. https://t.co/nomBFsBhbp

02 Jan 2020

Reply Repost Favourite

A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway. #lymphoma #lymsm https://t.co/PxJn6vPSrC

02 Jan 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.